Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Schilz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Gene Medicine|October 17, 2001
Optimization of retroviral vector generation for clinical applicationA J Schilz, K Kühlcke, A A Fauser, et al.
Gene Therapy|February 4, 1999
FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cellsM Hildinger, H G Eckert, A J Schilz, et al.
Bone Marrow Transplantation|August 10, 2000
Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1)H G Eckert, K Kühlcke, A J Schilz, et al.
Blood|October 27, 1998
High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditionsA J Schilz, G Brouns, H Knöss, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditionsA J Schilz, B Schiedlmeier, K Kühlcke, et al.
Gene Therapy|April 21, 2001
Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cellsR Knipper, K Kuehlcke, B Schiedlmeier, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Gene Medicine|October 17, 2001
Optimization of retroviral vector generation for clinical applicationA J Schilz, K Kühlcke, A A Fauser, et al.
Gene Therapy|February 4, 1999
FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cellsM Hildinger, H G Eckert, A J Schilz, et al.
Bone Marrow Transplantation|August 10, 2000
Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1)H G Eckert, K Kühlcke, A J Schilz, et al.
Blood|October 27, 1998
High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditionsA J Schilz, G Brouns, H Knöss, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditionsA J Schilz, B Schiedlmeier, K Kühlcke, et al.
Gene Therapy|April 21, 2001
Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cellsR Knipper, K Kuehlcke, B Schiedlmeier, et al.
Pageof 1